The development of insulin resistance in type 2 diabetes: Insights from knockout studies

Science Progress

Volumn 91, Issue 3, 2008, Pages 285-316

  Pattaranit, Ratchada ^a   van den Berg, Hugo Antonius ^b   Spanswick, David ^c  

^a UNIVERSITY OF WARWICK   (United Kingdom)

^b VU UNIVERSITY AMSTERDAM   (Netherlands)

^c UNIVERSITY OF WARWICK   (United Kingdom)

Author keywords

Cre loxP system; Diabetes; Glucose homeostasis; Glucose transporter; Hyperglycemia; Hyperinsulinemia; Insulin; Insulin receptor; Insulin resistance; Transgenic knockout

Indexed keywords

EID: 53949103316     PISSN: 00368504     EISSN: None     Source Type: Journal    
DOI: 10.3184/003685008X361343     Document Type: Review

References (63)

1. Wild, S., Roglic, G., Green, A., Sicree, R. and King, H. (2004) Global prevalence of diabetes, estimates for the year 2000 and projections for 2030. Diabetes Care, 27(5), 1047-1053.
2. Boden, G., Chen, X., Ruiz, J., White, J. V. and Rossetti, L. (1994) Mechanisms of fatty acid-induced inhibition of glucose uptake. J. Clin. Invest., 93(6), 2438-2446.
3. Bergman, R. N. and Ader, M. (2000) Free fatty acids and pathogenesis of type 2 diabetes mellitus. Trends Endocrinol. Metab., 11(9), 351-6.
4. Mlinar, B., Marc, J., Janez, A. and Pfeifer, M. (2007) Molecular mechanisms of insulin resistance and associated diseases. Clin. Chim. Acta, 375(1-2), 20-35.
5. Boden, G. and Chen, X. (1999) Effects of fatty acids and ketone bodies on basal insulin secretion in type 2 diabetes. Diabetes, 48(3), 577-583.
6. Webber, J. (2003) Energy balance in obesity. Proc. Nutr. Soc., 62(2), 539-543.
7. Kershaw, E. E. and Flier, J. S. (2004) Adipose tissue as an endocrine organ. J. Clin. Endocrinol. Metab., 89(6), 2548-2556.
8. Saltiel, A. R. and Kahn, C. R. (2001) Insulin signalling and the regulation of glucose and lipid metabolism. Nature, 414(6865), 799-806.
9. Lamothe, B., Baudry, A., Desbois, P. et al. (1998) Genetic engineering in mice, impact on insulin signalling and action. Biochem. J., 335 (Pt 2), 193-204.
10. Kahn, C. R. (2003) Knockout mice challenge our concepts of glucose homeostasis and the pathogenesis of diabetes. Exp. Diabesity Res., 4(3), 169-182.
11. Myers, M. G. Jr. and White, M. F. (1996) Insulin signal transduction and the IRS proteins. Annu. Rev. Pharmacol. Toxicol., 36, 615-58.
12. Joost, H. G. and Thorens, B. (2001) The extended GLUT-family of sugar/ polyol transport facilitators, nomenclature, sequence characteristics, and potential function of its novel members (review). Mol. Mernbr. Biol., 18(4), 247-256.
13. Louvi, A., Accili, D. and Efstratiadis, A. (1997) Growth-promoting interaction of IGF-II with the insulin receptor during mouse embryonic development. Dev. Biol., 189(1), 33-48.
14. Joshi, R. L., Lamothe, B., Cordonnier, N. et al. (1996) Targeted disruption of the insulin receptor gene in the mouse results in neonatal lethality. Embo. J., 15(7), 1542-1547.
15. Accili, D., Drago, J., Lee, E. J. et al. (1996) Early neonatal death in mice homozygous for a null allele of the insulin receptor gene. Nat. Genet., 12(1), 106-109.
16. Virkamaki, A., Ueki, K. and Kahn, C. R. (1999) Protein-protein interaction in insulin signaling and the molecular mechanisms of insulin resistance. J. Clin. Invest., 103(7), 931-943.
17. Tamemoto, H., Kadowaki, T, Tobe, K. et al. (1994) Insulin resistance and growth retardation in mice lacking insulin receptor substrate-1. Nature, 372(6502), 182-186.
18. Araki, E., Lipes, M. A., Patti, M. E. et al. (1994) Alternative pathway of insulin signalling in mice with targeted disruption of the IRS-1 gene. Nature, 372(6502), 186-190.
19. Kulkarni, R. N., Winnay, J. N., Daniels, M. et al. (1999) Altered function of insulin receptor substrate-1-deficient mouse islets and cultured beta-cell lines. J. Clin. Invest., 104(12), R69-75.
20. Aspinwall, C. A., Lakey, J. R. and Kennedy, R. T (1999) Insulin-stimulated insulin secretion in single pancreatic beta cells. J. Biol. Chem., 274(10), 6360-6365.
21. Abe, H., Yamada, N., Kamata, K. et al. (1998) Hypertension, hypertriglyceridemia, and impaired endothelium-dependent vascular relaxation in mice lacking insulin receptor substrate-1. J. Clin. Invest., 101(8), 1784-1788.
22. Withers, D. J., Gutierrez, J. S., Towery, H. et al. (1998) Disruption of IRS-2 causes type 2 diabetes in mice. Nature, 391(6670), 900-4.
23. Kubota, N., Tobe, K., Terauchi, Y. et al. (2000) Disruption of insulin receptor substrate 2 causes type 2 diabetes because of liver insulin resistance and lack of compensatory beta-cell hyperplasia. Diabetes, 49(11), 1880-1889.
24. Mauvais-Jarvis, F., Kulkarni, R. N. and Kahn, C. R. (2002) Knockout models are useful tools to dissect the pathophysiology and genetics of insulin resistance. Clin. Endocrinol. (Oxf.), 57(1), 1-9.
25. Fantin, V. R., Wang, Q., Lienhard, G. E. and Keller, S. R. (2000) Mice lacking insulin receptor substrate 4 exhibit mild defects in growth, reproduction, and glucose homeostasis. Am. J.. Physiol. Endocrinol. Metab., 278(1), E127-133.
26. Elchebly, M., Payette, P., Michaliszyn, E. et al. (1999) Increased insulin sensitivity and obesity resistance in mice lacking the protein tyrosine phosphatase-1B gene. Science, 283(5407), 1544-1548.
27. Klaman, L. D., Boss, O., Peroni, O. D. et al. (2000) Increased energy expenditure, decreased adiposity, and tissue-specific insulin sensitivity in protein-tyrosine phosphatase 1B-deficient mice. Mol. Cell. Biol., 20(15), 5479-5489.
28. Mauvais-Jarvis, F. and Kahn, C. R. (2000) Understanding the pathogenesis and treatment of insulin resistance and type 2 diabetes mellitus, what can we learn from transgenic and knockout mice? Diabetes Metab., 26(6), 433-448.
29. Terauchi, Y., Tsuji, Y., Satoh, S. et al. (1999) Increased insulin sensitivity and hypoglycaemia in mice lacking the p85 alpha subunit of phosphoinositide 3-kinase. Nat. Genet., 21(2), 230-235.
30. Katz, E. B., Stenbit, A. E., Hatton, K., DePinho, R. and Charron, M. J. (1995) Cardiac and adipose tissue abnormalities but not diabetes in mice deficient in GLUT4. Nature, 377(6545), 151-155.
31. Bruning, J. C., Winnay, J., Cheatham, B. and Kahn C. R. (1997) Differential signaling by insulin receptor substrate 1 (IRS-1) and IRS-2 in IRS-1-deficient cells. Mol. Cell. Biol., 17(3), 1513-1521.
32. Kido, Y., Burks, D. J., Withers, D. et al. (2000) Tissue-specific insulin resistance in mice with mutations in the insulin receptor, IRS-1, and IRS-2. J. Clin. Invest., 105(2), 199-205.
33. Mauvais-Jarvis, E, Ueki, K., Fruman, D. A. et al. (2002) Reduced expression of the murine p85alpha subunit of phosphoinositide 3-kinase improves insulin signaling and ameliorates diabetes. J. Clin. Invest., 109(1), 141-149.
34. Laustsen, P. G., Michael, M. D., Crute, B. E. et al. (2002) Lipoatrophic diabetes in Irs1(-/-)/Irs3(-/-) double knockout mice. Genes Dev., 16(24), 3213-3222.
35. Curtis, S. E. M. M., Crute, B. E., Keller, S. R. and Lienhard, G. E. (2000) Double knockout of IRS proteins reveals critical roles of IRS-1 and IRS-3 in the maintenance of glucose homeostasis (abstract). Keystone Symposia, A5.
36. Kahn, C. R. (1994) Banting Lecture. Insulin action, diabetogenes, and the cause of type II diabetes. Diabetes, 43(8), 1066-1084.
37. Bruning, J. C., Michael, M. D., Winnay, J. N. et al. (1998) A muscle-specific insulin receptor knockout exhibits features of the metabolic syndrome of NIDDM without altering glucose tolerance. Mol. Cell., 2(5), 559-569.
38. Lauro, D., Kido, Y., Castle, A. L. et al. (1998) Impaired glucose tolerance in mice with a targeted impairment of insulin action in muscle and adipose tissue. Nat. Genet., 20(3), 294-298.
39. Mauvais-Jarvis, F., Virkamaki, A., Michael, M. D. et al. (2000) A model to explore the interaction between muscle insulin resistance and beta-cell dysfunction in the development of type 2 diabetes. Diabetes, 49(12), 2126-2134.
40. Kim, J. K., Michael, M. D., Previs, S. F. et al. (2000) Redistribution of substrates to adipose tissue promotes obesity in mice with selective insulin resistance in muscle. J. Clin. Invest., 105(12), 1791-1797.
41. Wojtaszewski, J. F., Higaki, Y., Hirshman, M. F. et al. (1999) Exercise modulates postreceptor insulin signaling and glucose transport in muscle-specific insulin receptor knockout mice. J Clin. Invest., 104(9), 1257-1264.
42. Michael, M. D., Kulkarni, R. N., Postic, C. et al. (2000) Loss of insulin signaling in hepatocytes leads to severe insulin resistance and progressive hepatic dysfunction. Mol. Cell., 6(1), 87-97.
43. Cohen, S. E., Kokkotou, E., Biddinger, S. B. et al. (2007) High circulating leptin receptors with normal leptin sensitivity in liver-specific insulin receptor knock-out (LIRKO) mice. J Biol. Chem., 282(32), 23672-23678.
44. Kulkarni, R. N., Bruning, J. C., Winnay, J. N., Postic, C., Magnuson, M. A. and Kahn, C. R. (1999) Tissue-specific knockout of the insulin receptor in pancreatic beta cells creates an insulin secretory defect similar to that in type 2 diabetes. Cell., 96(3), 329-339.
45. Bluher, M., Michael, M. D., Peroni, O. D. et al. (2002) Adipose tissue selective insulin receptor knockout protects against obesity and obesity-related glucose intolerance. Dev. Cell., 3(1), 25-38.
46. Bluher, M., Kahn, B. B. and Kahn, C. R. (2003) Extended longevity in mice lacking the insulin receptor in adipose tissue. Science, 299(5606), 572-574.
47. Bluher, M., Patti, M. E., Gesta, S., Kahn, B. B. and Kahn, C. R. (2004) Intrinsic heterogeneity in adipose tissue of fat-specific insulin receptor knock-out mice is associated with differences in patterns of gene expression. J. Biol. Chem., 279(30), 31891-31901.
48. Havrankova, J., Roth, J. and Brownstein, M. (1978) Insulin receptors are widely distributed in the central nervous system of the rat. Nature, 272(5656), 827-829.
49. Binning, J. C., Gautam, D., Burks, D. J. et al. (2000) Role of brain insulin receptor in control of body weight and reproduction. Science, 289(5487), 2122-2125.
50. Lowell, B. B., V, S. S., Hamann, A. et al. (1993) Development of obesity in transgenic mice after genetic ablation of brown adipose tissue. Nature, 366(6457), 740-742.
51. Guerra, C., Navarro, P., Valverde, A. M. et al. (2001) Brown adipose tissue-specific insulin receptor knockout shows diabetic phenotype without insulin resistance. J. Clin. Invest., 108(8), 1205-1213.
52. Zisman, A., Peroni, O. D., Abel, E. D. et al. (2000) Targeted disruption of the glucose transporter 4 selectively in muscle causes insulin resistance and glucose intolerance. Nat. Med., 6(8), 924-928.
53. Kim, Y. B., Peroni, O. D., Aschenbach, W. G. et al. (2005) Muscle-specific deletion of the Glut4 glucose transporter alters multiple regulatory steps in glycogen metabolism. Mol. Cell. Biol., 25(21), 9713-9723.
54. Kim, J. K., Zisman, A., Fillmore, J. J. et al. (2001) Glucose toxicity and the development of diabetes in mice with muscle-specific inactivation of GLUT4. J Clin. Invest., 108(1), 153-160.
55. Carvalho, E., Kotani, K., Peroni, O. D. and Kahn, B. B. (2005) Adipose-specific overexpression of GLUT4 reverses insulin resistance and diabetes in mice lacking GLUT4 selectively in muscle. Am. J. Physiol. Endocrinol. Metab., 289(4), E551-61.
56. Abel, E. D., Peroni, O., Kim, J.K. et al. (2001) Adipose-selective targeting of the GLUT4 gene impairs insulin action in muscle and liver. Nature, 409(6821), 729-733.
57. Kotani, K., Peroni, O. D., Minokoshi, Y., Boss, O. and Kahn, B. B. (2004) GLUT4 glucose transporter deficiency increases hepatic lipid production and peripheral lipid utilization. J Clin. Invest., 114(11), 1666-1675.
58. Wallberg-Henriksson, H. and Zierath, J. R. (2001) GLUT4, a key player regulating glucose homeostasis? Insights from transgenic and knockout mice (review). Mol. Membr. Biol., 18(3), 205-211.
59. Ren, J. M., Marshall, B. A., Mueckler, M. M., McCaleb, M., Amatruda, J. M. and Shulman, G. I. (1995) Overexpression of Glut4 protein in muscle increases basal and insulin-stimulated whole body glucose disposal in conscious mice. J. Clin. Invest., 95(1), 429-432.
60. Tozzo, E., Gnudi, L. and Kahn, B. B. (1997) Amelioration of insulin resistance in streptozotocin diabetic mice by transgenic overexpression of GLUT4 driven by an adipose-specific promoter. Endocrinology, 138(4), 1604-1611.
61. Leturque, A., Loizeau, M., Vaulont, S., Salminen, M. and Girard, J. (1996) Improvement of insulin action in diabetic transgenic mice selectively overexpressing GLUT4 in skeletal muscle. Diabetes, 45(1), 23-27.
62. Tiikkainen, M., Hakkinen, A. M., Korsheninnikova, E., Nyman, T., Makimattila, S. and Yki-Jarvinen, H. (2004) Effects of rosiglitazone and metformin on liver fat content, hepatic insulin resistance, insulin clearance, and gene expression in adipose tissue in patients with type 2 diabetes. Diabetes, 53(8), 2169-2176.
63. Kitamura, T., Kahn, C. R. and Accili D., (2003) Insulin receptor knockout mice. Annu. Rev. Physiol., 65, 313-332.